Skip to content
Review Open access

Advances in the development and delivery of nucleic acid-based therapeutics.

Aug 2026 · Biomaterials Science · 0 citations
Medicine

TL;DR

Self-amplifying RNA, circular RNA, CRISPR systems, antisense oligonucleotides, and antibody-oligonucleotide conjugates are presented, as well as CAR modification of T-cells, natural killer cells, and macrophages, with a brief discussion of modified stem cells.

Abstract

Recent advancements in experimental and computational methods along with growing gene sequencing libraries have enabled rapid development of nucleic acid-based therapeutic design for a wide variety of diseases. New drugs, delivery tools and methods have enabled precise and efficient therapy at a molecular scale. This review covers the current landscape and future directions of methods for gene and cell therapies, as well as their applications, advantages, and limitations. We present self-amplifying RNA, circular RNA, CRISPR systems, antisense oligonucleotides, and antibody-oligonucleotide conjugates, as well as CAR modification of T-cells, natural killer cells, and macrophages, with a brief discussion of modified stem cells. We also discuss developments in viral and non-viral delivery systems for their applications in cell and gene therapies.

Read PDF

Similar papers

Review Open access Aug 2026

Design And Optimization Of Nucleic Acid Delivery Systems For Clinical Applications: A Review

This article provides a comprehensive overview of the evolving landscape of nucleic acid-based therapeutics and aims to inform clinicians, researchers, and pharmaceutical scientists about their current applications and future potential in modern healthcare.

Satyaraj Ombase, Shanmugarathanam Alagarsamy, R. Prasad et al. · 0 citations
Review Aug 2026

RNA Therapeutics and Delivery Strategies: Innovations, Challenges, and Clinical Translation

The different forms of RNA-based treat-ments, such as messenger RNAs, small interfering RNAs, and circular RNAs, are discussed in this paper along with their significance in gene regulation and the treatment of disease.

Avinash Verma, Shaweta Sharma · 0 citations
Review Dec 2024

Journal of Population Therapeutics & Clinical Pharmacology

This review starts by examining the advantages and limitations of various physical methods for delivering Cas9, and highlights key applications of CRISPR systems in epigenetic modifications, and explores the use of CRISPR-Cas9 technology in genome editing, with a particular focus on base editing and prime editing.

Suhail Ahmad Sheikh, W. Shah, Azka Khan et al. · 0 citations
Review Open access Sep 2026

Nonviral nucleic acid delivery systems: specific features of polymeric carriers

Gene therapy has found wide use in the prevention and treatment of cancer, infectious diseases, and neurodegenerative and metabolic disorders. Meanwhile, the development of formulations providing effective and targeted delivery of nucleic acids has been and remains a challenging interdisciplinary task. Polymeric system...

E. Shaputkin, I. Nifant'ev, P. Ivchenko · 0 citations
Review Open access Aug 2026

Advances in gene transfer technologies: comparing viral and non-viral vectors for therapeutic applications

This review provides a comprehensive overview of the current status of viral and non-viral vector systems for in vivo and ex vivo applications, and key comparisons are made across safety, efficacy, scalability, and immune responses.

Praveen Halagali, Raagul Seenivasan, Amatha Sreedevi et al. · 1 citation
Sep 2026

Design Considerations for Next-Generation Protein–Nucleic Acid Conjugates in Biorecognition and Therapy

Proteins and nucleic acids represent nature’s most versatile biomolecules. By leveraging the functionality of proteins and the programmability of nucleic acids, along with the exquisite recognition properties of both, protein-nucleic acid conjugates can unlock hybrid systems that outperform either component alone. In...

Sasha B. Ebrahimi, Devleena Samanta · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.